Sensei Biotherapeutics Inc expected to post a loss of 31 cents a share - Earnings Preview

Faeth Therapeutics,

04/08/2023 19:38

* Sensei Biotherapeutics Inc  SNSE.OQ   SNSE.O  is expected
to report  results 
    * 
    * ​Refinitiv's mean analyst estimate for Sensei
Biotherapeutics
Inc is for a loss of 31 cents per share. 
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 2 "strong buy" or "buy," 1
"hold" and no "sell" or "strong sell."  
    * The mean earnings estimate of analysts had risen by
about 5.8%
in the last three months. ​
    * Wall Street's median 12-month price target for Sensei
Biotherapeutics Inc is $6​, above​ its last closing price
of $1.20. ​​​

This summary was machine generated August 4 at 18:38 GMT.  All
figures in US dollars  unless otherwise stated